$CNFN
CFN Enterprises Inc.

2018 Q1 Form 10-Q Financial Statement

#000143774918009986 Filed on May 15, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $5.993M $5.957M
YoY Change 0.6% 1.58%
Cost Of Revenue $2.354M $1.545M
YoY Change 52.32% -20.02%
Gross Profit $3.639M $4.411M
YoY Change -17.51% 12.19%
Gross Profit Margin 60.72% 74.06%
Selling, General & Admin $3.170M $1.926M
YoY Change 64.59% -15.84%
% of Gross Profit 87.12% 43.67%
Research & Development $1.123M $1.043M
YoY Change 7.62% 1.23%
% of Gross Profit 30.85% 23.65%
Depreciation & Amortization $119.1K $169.0K
YoY Change -29.56% -35.99%
% of Gross Profit 3.27% 3.83%
Operating Expenses $4.293M $4.186M
YoY Change 2.56% -2.93%
Operating Profit -$654.1K $225.5K
YoY Change -390.03% -159.33%
Interest Expense $0.00 -$280.0K
YoY Change -100.0% 40.0%
% of Operating Profit -124.15%
Other Income/Expense, Net -$602.4K -$280.8K
YoY Change 114.55% 38.24%
Pretax Income -$460.0K -$60.00K
YoY Change 666.67% -89.66%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.256M -$55.22K
YoY Change 2175.2% -90.53%
Net Earnings / Revenue -20.97% -0.93%
Basic Earnings Per Share -$0.02 $0.00
Diluted Earnings Per Share -$0.02 $0.00
COMMON SHARES
Basic Shares Outstanding 65.94M 65.26M
Diluted Shares Outstanding 65.94M 65.26M

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $810.0K $510.0K
YoY Change 58.82% -52.78%
Cash & Equivalents $805.9K $513.6K
Short-Term Investments
Other Short-Term Assets $500.0K $590.0K
YoY Change -15.25% 168.18%
Inventory
Prepaid Expenses
Receivables $2.856M $2.323M
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.157M $3.425M
YoY Change 21.39% 0.95%
LONG-TERM ASSETS
Property, Plant & Equipment $82.04K $3.288M
YoY Change -97.5% 52.01%
Goodwill
YoY Change
Intangibles $4.196M
YoY Change
Long-Term Investments
YoY Change
Other Assets $125.9K $103.4K
YoY Change 21.78% -10.52%
Total Long-Term Assets $4.403M $3.391M
YoY Change 29.86% 48.84%
TOTAL ASSETS
Total Short-Term Assets $4.157M $3.425M
Total Long-Term Assets $4.403M $3.391M
Total Assets $8.561M $6.816M
YoY Change 25.6% 20.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.240M $1.910M
YoY Change 17.28% -20.75%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $450.0K
YoY Change -100.0% -28.57%
Long-Term Debt Due $3.240M $2.220M
YoY Change 45.95% -51.1%
Total Short-Term Liabilities $5.962M $4.671M
YoY Change 27.64% -38.54%
LONG-TERM LIABILITIES
Long-Term Debt $6.840M $4.520M
YoY Change 51.33%
Other Long-Term Liabilities $956.3K $1.381M
YoY Change -30.77%
Total Long-Term Liabilities $956.3K $1.381M
YoY Change -30.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.962M $4.671M
Total Long-Term Liabilities $956.3K $1.381M
Total Liabilities $13.76M $10.57M
YoY Change 30.21% 38.99%
SHAREHOLDERS EQUITY
Retained Earnings -$32.80M -$29.17M
YoY Change 12.43% 12.86%
Common Stock $65.94K $65.28K
YoY Change 1.0% 0.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.199M -$3.752M
YoY Change
Total Liabilities & Shareholders Equity $8.561M $6.816M
YoY Change 25.6% 20.19%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$1.256M -$55.22K
YoY Change 2175.2% -90.53%
Depreciation, Depletion And Amortization $119.1K $169.0K
YoY Change -29.56% -35.99%
Cash From Operating Activities -$1.100M -$659.6K
YoY Change 66.74% -402.0%
INVESTING ACTIVITIES
Capital Expenditures $13.40K $9.799K
YoY Change 36.77%
Acquisitions
YoY Change
Other Investing Activities -$380.0K -$510.0K
YoY Change -25.49% 8.51%
Cash From Investing Activities -$388.4K -$524.5K
YoY Change -25.94% 11.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.110M 13.45K
YoY Change 15582.0% -96.89%
NET CHANGE
Cash From Operating Activities -1.100M -659.6K
Cash From Investing Activities -388.4K -524.5K
Cash From Financing Activities 2.110M 13.45K
Net Change In Cash 639.0K -1.171M
YoY Change -154.59% -749.18%
FREE CASH FLOW
Cash From Operating Activities -$1.100M -$659.6K
Capital Expenditures $13.40K $9.799K
Free Cash Flow -$1.113M -$669.4K
YoY Change 66.3% -406.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 aclz Common Stock Issued And Outstanding Percentage Decrease
CommonStockIssuedAndOutstandingPercentageDecrease
0.03
CY2018Q1 aclz Fair Value Of Options And Warrants
FairValueOfOptionsAndWarrants
99352
CY2017Q1 aclz Fair Value Of Options And Warrants
FairValueOfOptionsAndWarrants
219700
CY2018Q1 aclz Fair Value Of Warrants Issued In Connection With Line Of Credit
FairValueOfWarrantsIssuedInConnectionWithLineOfCredit
1156695
CY2017Q1 aclz Fair Value Of Warrants Issued In Connection With Line Of Credit
FairValueOfWarrantsIssuedInConnectionWithLineOfCredit
CY2018Q1 aclz Foreign Currency Translation Gain Loss Accumulated Depreciation
ForeignCurrencyTranslationGainLossAccumulatedDepreciation
4977
CY2018Q1 aclz Foreign Currency Translation Gain Loss Property Plant And Equipment
ForeignCurrencyTranslationGainLossPropertyPlantAndEquipment
-11651
CY2018Q1 aclz Other Finance Fees
OtherFinanceFees
28655
CY2017Q1 aclz Other Finance Fees
OtherFinanceFees
24125
CY2018Q1 aclz Payables And Loan Paid By Credit Facility
PayablesAndLoanPaidByCreditFacility
623399
CY2017Q1 aclz Payables And Loan Paid By Credit Facility
PayablesAndLoanPaidByCreditFacility
CY2018Q1 aclz Prepaid Expenses Reclassed To Deferred Financing Cost
PrepaidExpensesReclassedToDeferredFinancingCost
70000
CY2017Q1 aclz Prepaid Expenses Reclassed To Deferred Financing Cost
PrepaidExpensesReclassedToDeferredFinancingCost
CY2018Q1 aclz Repayment Of Loan Noncash Investing And Financing Activities
RepaymentOfLoanNoncashInvestingAndFinancingActivities
CY2017Q1 aclz Repayment Of Loan Noncash Investing And Financing Activities
RepaymentOfLoanNoncashInvestingAndFinancingActivities
25000
CY2017Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
133573
CY2017Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
CY2018Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
105000
CY2018Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
235703
CY2017Q1 aclz Stock Issued During Period Shares Stock Options Exercised Noncash
StockIssuedDuringPeriodSharesStockOptionsExercisedNoncash
1707692
CY2017Q1 aclz Stock Issued During Period Shares Warrants Exercised Noncash
StockIssuedDuringPeriodSharesWarrantsExercisedNoncash
160096
CY2018Q1 aclz Working Capital Deficit
WorkingCapitalDeficit
-1804833
CY2018Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2242116
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2479083
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2856152
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2692636
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
794189
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
775152
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23910
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-41540
CY2018Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
27557795
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26301748
CY2018Q1 us-gaap Advertising Cost Policy Expensed Advertising Cost
AdvertisingCostPolicyExpensedAdvertisingCost
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Advertising</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company expenses advertising costs as incurred.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table style="; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Three-month periods ended</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">March 31,</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2017</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 70%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Advertising expense</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">133,548</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">86,416</div></td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div></div></div>
CY2018Q1 us-gaap Advertising Expense
AdvertisingExpense
133548
CY2017Q1 us-gaap Advertising Expense
AdvertisingExpense
86416
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
471144
CY2018Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
202898
CY2017Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
59807
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
23063359
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16275714
CY2018Q1 us-gaap Assets
Assets
8560953
CY2017Q4 us-gaap Assets
Assets
7575914
CY2018Q1 us-gaap Assets Current
AssetsCurrent
4157481
CY2017Q4 us-gaap Assets Current
AssetsCurrent
3457862
CY2018Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6622
CY2018Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
4196000
CY2017Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
3926000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
166883
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1680127
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
805880
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
513641
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
638997
CY2017Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1166486
CY2018Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65939709
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65939709
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65939709
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65939709
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
65938
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
65938
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1238829
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51144
CY2018Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Concentration of Credit Risks</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company is subject to concentrations of credit risk primarily from cash and cash equivalents and accounts receivable.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company&#x2019;s cash and cash equivalents accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$250,000.</div> During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-month period ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2018, </div>the Company has reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of the financial institution in which it holds deposits.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company's accounts receivable are due from customers, generally located in the United States, Europe, Asia, and Canada. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">None</div> of the Company&#x2019;s customers accounted for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of its accounts receivable at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2018 </div>or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.&nbsp;&nbsp;</div>The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require any collateral from its customers.</div></div></div></div>
CY2018Q1 us-gaap Cost Of Revenue
CostOfRevenue
2353860
CY2017Q1 us-gaap Cost Of Revenue
CostOfRevenue
1545345
CY2018Q1 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
1457249
CY2017Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
245584
CY2018Q1 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0
CY2017Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
0
CY2018Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
0
CY2017Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
82868
CY2018Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
476831
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
299937
CY2018Q1 us-gaap Depreciation
Depreciation
14059
CY2017Q1 us-gaap Depreciation
Depreciation
35455
CY2018Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
119059
CY2017Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
169028
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
17630
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
4080
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
35382
CY2018Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y180D
CY2018Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2617203
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2512203
CY2018Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6812726
CY2017Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6437726
CY2018Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4195523
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3925523
CY2018Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3243367
CY2017Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
3055812
CY2018Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
CY2017Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-902
CY2016 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-2200000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1999886
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1926242
CY2018Q1 us-gaap Gross Profit
GrossProfit
3638888
CY2017Q1 us-gaap Gross Profit
GrossProfit
4411379
CY2018Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2017Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2018Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-308112
CY2017Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-860096
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-71925
CY2017Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
95718
CY2018Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
176894
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
40583
CY2018Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2783
CY2017Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
813
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-32894
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
140115
CY2018Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4195523
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3925523
CY2018Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
373257
CY2017Q1 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
196590
CY2018Q1 us-gaap Interest Paid Net
InterestPaidNet
373257
CY2017Q1 us-gaap Interest Paid Net
InterestPaidNet
196590
CY2018Q1 us-gaap Liabilities
Liabilities
13760273
CY2017Q4 us-gaap Liabilities
Liabilities
12792452
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8560953
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7575914
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
5962314
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7059026
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
225528
CY2018Q1 us-gaap Litigation Reserve
LitigationReserve
1381250
CY2018Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
6841709
CY2017Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
4402988
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2109542
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13452
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-388402
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-524458
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1099773
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-659560
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-1256459
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-55224
CY2018Q1 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
761
CY2017Q1 us-gaap Nonoperating Gains Losses
NonoperatingGainsLosses
-300
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-602354
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-280752
CY2018Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2017Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
4292993
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
4185851
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-654105
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
125906
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
123124
CY2018Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
17630
CY2017Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
4080
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
17630
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4080
CY2018Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
956250
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1062500
CY2018Q1 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
CY2017Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
267938
CY2018Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
603115
CY2017Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
280452
CY2018Q1 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
CY2017Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
1224194
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13402
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9799
CY2018Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
375000
CY2017Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
515454
CY2018Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
445449
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
548343
CY2018Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
3771600
CY2017Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
500000
CY2018Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
CY2017Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
795
CY2018Q1 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
CY2018Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
876232
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
844557
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82043
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
69405
CY2018Q1 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P3Y
CY2018Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-235441
CY2017Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2386
CY2018Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
662058
CY2017Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
486548
CY2018Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1000000
CY2017Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1122623
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1043119
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
50000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
50000
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32799143
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31542684
CY2018Q1 us-gaap Revenues
Revenues
5992748
CY2017Q1 us-gaap Revenues
Revenues
5956724
CY2018Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1170484
CY2017Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1216490
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
45000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
257500
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.40
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.43
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8257500
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8302500
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.40
CY2018Q1 us-gaap Stock Issued1
StockIssued1
CY2017Q1 us-gaap Stock Issued1
StockIssued1
1868
CY2018Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2017Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2400000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-5199320
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-5216538
CY2017Q4 us-gaap Subordinated Debt
SubordinatedDebt
625000
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65262289
CY2018Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65939709
CY2017Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
65262289
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets, and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</div></div></div></div>
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
65939709
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65939709
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
65262289

Files In Submission

Name View Source Status
0001437749-18-009986-index-headers.html Edgar Link pending
0001437749-18-009986-index.html Edgar Link pending
0001437749-18-009986.txt Edgar Link pending
0001437749-18-009986-xbrl.zip Edgar Link pending
aclz-20180331.xml Edgar Link completed
aclz-20180331.xsd Edgar Link pending
aclz-20180331_cal.xml Edgar Link unprocessable
aclz-20180331_def.xml Edgar Link unprocessable
aclz-20180331_lab.xml Edgar Link unprocessable
aclz-20180331_pre.xml Edgar Link unprocessable
aclz20180331_10q.htm Edgar Link pending
ex_113364.htm Edgar Link pending
ex_113365.htm Edgar Link pending
ex_113366.htm Edgar Link pending
ex_113367.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending